A. The drug inhibits the enzyme cyclooxygenase in platelets thereby reducing the thromboxane
Thromboxane is produced by activated platelets during hemostasis it stimulates activation of platelets and platelet aggregation, by activating the thromboxane receptor, which causes change in shape of platelets, activation of integrins, and degranulation of platelets. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot. It is also a vasoconstrictor
B. It reversibly binds lysine receptor sites on plasminogen. This reduces conversion of plasminogen to plasmin, preventing fibrin degradation .
In secondry polycythemia there is increased tendency for thrombosis, which recruits more platelets for thrombosis and increased fibrin degradation products which may trigger DIC and lead to bleeding
For the essay that you pick, if there is a relevant pathway to outline, YOU MUST OUTLINE THE PATHWAY ON NEXT PAGE M...
For the essay that you pick, if there is a relevant pathway to outline, YOU M NEXT PAGE MARKED PATHwAY" UST OUTLINE THE PATHWAY ON and then attempt to answer the problem. NO OUTLINE-NO POINTS the next Dr. Frankenstein and are analyzing a series of anti-hemostatic/hemostatic agents to bring back the "DEAD(ie. ZOMBIES) and a way to kill them. Your administering the drug, you slash their wrists and also do isolated damage to the blood vessinnetunica intimal damage on y...
3. You are determining the mode of action of a number of blood pressure modifying drugs. Based on the observations below, theorize how the following compounds prevent a homeostatic balance to blood pressure. e appropriate pathway on the next page, answer the following: When you exercise ows on your diagram to explain what is happening to your body to maintain a proper please explain and/or use arro MAP, assuming the appropriate changes in cardiac output when B) Your subject started...